packageRemibrutinib

remibrutinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Remibrutinib is an immunosuppressant used to treat urticaria. It is authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q123499462 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:remibrutinib
ATC codes:L04AA60
DrugBank:DB16852
PubChem CID:118107483
Wikidata:Q123499462
formula:C27H27F2N5O3
molar mass:507.541 g/mol (PubChem CID 118107483)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown